Statement Of Cash Flows [Abstract]
| Concept |
2023-01-01 to 2023-12-31 |
2022-01-01 to 2022-12-31 |
|---|---|---|
| Statement of cash flows [abstract] | ||
| Cash flows from (used in) operating activities [abstract] | ||
| Adjustments for decrease (increase) in trade and other receivables |
113,955,000
DKK
|
208,951,000
DKK
|
| Adjustments for depreciation and amortisation expense and impairment loss (reversal of impairment loss) recognised in profit or loss |
637,209,000
DKK
|
537,480,000
DKK
|
| Adjustments for gains (losses) on change in fair value less costs to sell, biological assets |
141,665,000
DKK
|
278,392,000
DKK
|
| Adjustments for undistributed profits of investments accounted for using equity method |
70,652,000
DKK
|
57,597,000
DKK
|
| Cash flows from (used in) financing activities [abstract] | ||
| Cash flows from (used in) increase (decrease) in current borrowings |
546,241,000
DKK
|
735,352,000
DKK
|